The SMART BioSyM IRG has three major areas of focus. First and foremost is the development of new technologies to address critical medical and biological questions applicable to a variety of diseases. Second, is the further development of these technologies to provide novel solutions for the healthcare industry. Third, is to provide a constant source of new technologies to the broader Singapore research infrastructure.
BioSyM brings together a multidisciplinary team of faculties and researchers from MIT and Singapore's Universities (NUS and NTU) and Research Institutes. Collaborate with researchers from Universities, Research Institutes and industries in Singapore and Asia.
- To become the focal point for translating cutting edge science into novel technologies for human healthcare.
- To develop enabling biotechnologies that will create the next generation of scientific discoveries and will lead to advances in our understanding of biological phenomena and the development of new diagnostic/therapeutic assays and translation into clinical practice.